Close

aTyr Pharma (LIFE) Granted FDA Fast Track Status for Resolaris

October 24, 2016 8:03 AM EDT Send to a Friend
aTyr Pharma, Inc. (Nasdaq: LIFE) announced that its product candidate Resolaris™ was granted Fast Track designation by the US ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login